Advertisement

Journal of Cancer Survivorship

, Volume 9, Issue 2, pp 279–286 | Cite as

Effects of web-based intervention on risk reduction behaviors in melanoma survivors

  • Deborah J. BowenEmail author
  • Wylie Burke
  • Jennifer L. Hay
  • Hendrika Meischke
  • Julie N Harris
Article

Abstract

Purpose

Melanoma is the most severe form of skin cancer, and survivors of melanoma carry increased risk of additional melanoma diagnosis. Multiple methods exist for primary and secondary prevention of melanoma in survivors. This study tested a web-based family communication intervention to improve these preventive behaviors in melanoma families.

Methods

Families (a survivor, at least one first-degree relative and a parent) were randomized either to receive the intervention package or to serve as comparison families. We assessed melanoma prevention behaviors in each cohort member before and after the intervention. The intervention was a web-based multicomponent intervention focused on increasing family communication and exchange of risk information.

Results

Results indicated that, compared to comparison survivors, intervention survivors improved their skin self-examination and their sun protection behaviors significantly from before to after intervention.

Conclusion

These data support the use of web-based interventions for behavioral changes in survivors and allow for consideration of dissemination of this successful intervention. These data have implications for interventions that can help cancer families deal with issues of risk and illness.

Implications for cancer survivors

These data indicate that survivors can benefit from exposure to a website that helps direct their future health behaviors.

Keywords

Melanoma Prevention Web-based Family communication 

Notes

Conflict of interest

Authors Bowen, Burke, Hay, Meischke, and Harris declare that they have no conflicts of interest.

Informed consent

“All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. Informed consent was obtained from all patients for being included in the study.”

References

  1. 1.
    What are the key statistics about melanoma skin cancer? In: Melanoma Skin Cancer. American CancerSociety 2014; http://www.cancer.org/cancer/skincancer-melanoma/detailedguide/melanoma-skin-cancer-key-statistics.
  2. 2.
    SEER Cancer Statistics Review, 1975–2010, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2010/, based on November 2012 SEER data submission, posted to the SEER web site, April 2013. Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds).
  3. 3.
    ASCO 2011 Abstract: LBA5 Phase 3 randomized study of ipilimumab (IPI) plus dacarbazine (DTIC) vs DTIC alone as first line treatment in patients with unresectable stage III or IV melanoma. Wolchok JD, Thomas L, Bondarenko IN, O’Day S, Weber JS, Garbe C, Francis S, Ibrahim RA, Hoos A, Robert C.Google Scholar
  4. 4.
    Coyte A, Morrison DS, McLoone P. Second primary cancer risk—the impact of applying different definitions of multiple primaries: results from a retrospective population-based cancer registry study. BMC Cancer. 2014. doi: 10.1186/1471-2407-14-272.PubMedCentralPubMedGoogle Scholar
  5. 5.
    Begg CB, Hummer A, Mujumdar U, Armstrong BK, Kricker A, Marrett LD, et al. Familial aggregation of melanoma risks in a large population-based sample of melanoma cases. Cancer Causes Control. 2004. doi: 10.1007/s10552-004-2474-1.PubMedGoogle Scholar
  6. 6.
    Swetter SM, Pollitt RA, Johnson TM, Brooks DR, Geller AC. Behavioral determinants of successful early melanoma detection: role of self and physician skin examination. Cancer. 2012. doi: 10.1002/cncr.26707.PubMedCentralGoogle Scholar
  7. 7.
    Bichakjian CK, Halpern AC, Johnson TM, Hood AF, Grichnik J, Swetter SM, et al. Guidelines of care for the management of primary cutaneous melanoma. J Am Acad Dermatol. 2011. doi: 10.1016/j.jaad.2011.04.031.Google Scholar
  8. 8.
    Melanoma Skin Cancer. In Skin Cancer. American Cancer Society. 2013. http://www.cancer.org/acs/groups/cid/documents/webcontent/003120-pdf.pdf. Accessed 2 May 2014.
  9. 9.
    Chen ST, Geller AC, Tsao H. Update on the epidemiology of melanoma. Curr Dermatol Rep. 2013. doi: 10.1007/s13671-012-0035-5.PubMedCentralPubMedGoogle Scholar
  10. 10.
    Mujumdar UJ, Hay JL, Monroe-Hinds YC, Hummer AJ, Begg CB, Wilcox HB, et al. Sun protection and skin self-examination in melanoma survivors. Psycho-Oncology. 2009. doi: 10.1002/pon.1510.PubMedCentralPubMedGoogle Scholar
  11. 11.
    Manne S, Lessin S. Prevalence and correlates of sun protection and skin self-examination practices among cutaneous malignant melanoma survivors. J Behav Med. 2006. doi: 10.1007/s10865-006-9064-5.PubMedGoogle Scholar
  12. 12.
    Oliveria SA, Shuk E, Hay JL, Heneghan M, Goulart JM, Panageas K, et al. Melanoma survivors: health behaviors, surveillance, psychosocial factors, and family concerns. Psycho-Oncology. 2013. doi: 10.1002/pon.2059.PubMedGoogle Scholar
  13. 13.
    Körner A, Drapeau M, Thombs BD, Rosberger Z, Wang B, Khanna M, et al. Barriers and facilitators of adherence to medical advice on skin self-examination during melanoma follow-up care. BMC Dermatol. 2013. doi: 10.1186/1471-5945-13-3.PubMedCentralPubMedGoogle Scholar
  14. 14.
    Gritz ER, Tripp MK, Peterson SK, Prokhorov AV, Shete SS, Urbauer DL, Fellman BM, J Lee JE, Gershenwald JE. Randomized Controlled Trial of a Sun Protection Intervention for Children of Melanoma Survivors. Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 2013; doi: 10.1158/1055-9965.
  15. 15.
    Geller AC, Emmons KE, Brooks DR, Powers C, Zhang Z, Koh HK, et al. A randomized trial to improve early detection and prevention practices among siblings of melanoma patients. Cancer. 2006. doi: 10.1002/cncr.22050.Google Scholar
  16. 16.
    Bowen DJ, Jabson JM, Haddock N, Hay J, Edwards K. Skin care behaviors among melanoma survivors. Psycho-Oncology. 2011. doi: 10.1002/pon.2017.PubMedGoogle Scholar
  17. 17.
    Pitceathly C, Maguire P. The psychological impact of cancer on patients’ partners and other key relatives. Eur J Cancer. 2003. doi: 10.1016/S0959-8049(03)00309-5.PubMedGoogle Scholar
  18. 18.
    Novilla MLB, Barnes MD, Natalie G, Williams PN, Rogers J. Public health perspectives on the family: an ecological approach to promoting health in the family and community. Family Commun Health. 2006;29(1):28–42.CrossRefGoogle Scholar
  19. 19.
    Hay J, Shuk E, Brady MS, Berwick M, Ostroff J, Halpern A. Family communication after melanoma diagnosis. Arch Dermatol. 2008. doi: 10.1001/archderm.144.4.553.PubMedCentralGoogle Scholar
  20. 20.
    Geller 23296633 pulls up oliviera reference #13. The paper references #20 with respect to poor communication among family members about family risk.Google Scholar
  21. 21.
    Cappelli M et al. Psychological and social predictors of decisions about genetic testing for breast cancer in high-risk women. Psychol, Health Med. 2001;6(3):321–33.CrossRefGoogle Scholar
  22. 22.
    Friedman LC, Webb JA, Everett TE. Psychosocial and medical predictors of colorectal cancer screening among low-income medical outpatients. J Cancer Educ. 2004;19(3):180–6.CrossRefPubMedGoogle Scholar
  23. 23.
    McCaul KD et al. What is the relationship between breast cancer risk and mammography screening? A meta-analytic review. Health Psychol. 1996;15(6):423–9.CrossRefPubMedGoogle Scholar
  24. 24.
    Anton-Culver H et al. The cancer genetics network: recruitment results and pilot studies. Commun Genet. 2003;6(3):171–7.CrossRefGoogle Scholar
  25. 25.
    Bowen DJ, Hay JL, Mayer J, Kuniyuki A, Meischke H, Harris J, et al. Predictors of recruited melanoma families into a behavioral intervention project. Contemp Clin Trials. 2012;33(1):85–92.PubMedCentralCrossRefPubMedGoogle Scholar
  26. 26.
    Bowen DJ, Christensen CL, Powers D, Graves DR, Anderson CAM. Effects of counseling and ethnic identity on perceived risk and cancer worry in African American women. J Clin Psychol Med Settings. 1998;5:365–80.CrossRefGoogle Scholar
  27. 27.
    Bowen DJ, Burke W, McTiernan A, Powers D, Durfy S, Gralow J, et al. Participation in breast cancer risk counseling among women with a history of cancer. Cancer Epidemiol Biomarkers Prev. 1999;8:581–6. PMID: 1042819.PubMedGoogle Scholar
  28. 28.
    Bowen DJ, Powers D, Greenlee H. Effects of breast cancer risk counseling for sexual minority women. Health Care Women Int. 2005;27:59–74.CrossRefGoogle Scholar
  29. 29.
    Bowen DJ, Powers DM. Effects of a mail/telephone intervention on breast health behaviors. Health Educ Behav. 2010;37(4):479–89.CrossRefPubMedGoogle Scholar
  30. 30.
    Cancer Melanoma. In: Disease Risk Index. Harvard School of Public Health. 2008. http://www.diseaseriskindex.harvard.edu/update/hccpquiz.pl?lang=english&func=home&quiz=melanoma. Accessed 8 May 2014.
  31. 31.
    Weinstock M, Risica P, Martin R, Rakowski W, Dube C, Berwick M, et al. Melanoma early detection with thorough skin self-examination the ‘Check It Out’ randomized trial. Am J Prev Med. 2007. doi: 10.1016/j.amepre.2007.02.024.PubMedCentralPubMedGoogle Scholar
  32. 32.
    Oh SS, Mayer JA, Lewis EC, Slymen DJ, Sallis JF, Elder JP, et al. Validating outdoor workers’ self-report of sun protection. Prev Med. 2004;39(4):798–803.CrossRefPubMedGoogle Scholar
  33. 33.
    Lerman C, Daly M, Masny A, Balshem A. Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol. 1994;12(4):843–50.PubMedGoogle Scholar
  34. 34.
    Meropol NJ, Daly MB, Vig HS, Manion FJ, Manne SL, Mazar C, et al. Delivery of internet-based cancer genetic counselling services to patients’ homes: a feasibility study. J Telemed Telecare. 2011. doi: 10.1258/jtt.2010.100116.PubMedCentralPubMedGoogle Scholar
  35. 35.
    Manne S, Jacobsen PB, Ming ME, Winkel W, Dessureault S, Lessin SR. Tailored versus generic interventions for skin cancer risk reduction for family members of melanoma patients. Health Psychol: Off J Div Health Psychol, Am Psychol Assoc. 2010. doi: 10.1037/a0021387.Google Scholar
  36. 36.
    Kovalyshyn I. The impact of physician screening on melanoma detection. Arch Dermatol. 2011. doi: 10.1001/archdermatol.2011.181.PubMedGoogle Scholar
  37. 37.
    Lowery JT, Horick N, Kinney AY, Finkelstein DM, Garrett K, Haile RW, et al. A randomized trial to increase colonoscopy screening in members of high-risk families in the colorectal cancer family registry and cancer genetics network. Cancer Epidemiol Biomark Prev. 2014. doi: 10.1158/1055-9965.EPI-13-1085.Google Scholar
  38. 38.
    Torres SM, Ramos M, Leverence R, Bowen D, Berwick M, Hay J. A pilot study of skin cancer risk reduction behaviors, cancer communications, and skin cancer beliefs in Hispanics in a Southwestern primary care practice. Californian Journal of Health Promotion. 12:1; 95–100.Google Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Deborah J. Bowen
    • 1
    Email author
  • Wylie Burke
    • 1
  • Jennifer L. Hay
    • 2
  • Hendrika Meischke
    • 3
  • Julie N Harris
    • 4
  1. 1.Department of Bioethics and HumanitiesUniversity of WashingtonSeattleUSA
  2. 2.Department of Psychiatry and Behavioral SciencesMemorial Sloan-Kettering Cancer CenterNew YorkUSA
  3. 3.Department of Health ServicesUniversity of Washington School of Public HealthSeattleUSA
  4. 4.Kaiser Permanente Northern CaliforniaDivision of ResearchOaklandUSA

Personalised recommendations